The Role of Serum Levels of Neurofilament Light (NfL) Chain as a Biomarker in Friedreich Ataxia
Front Neurosci
.
2021 Mar 2:15:653241.
doi: 10.3389/fnins.2021.653241.
eCollection 2021.
Authors
Bernice Frempong
1
2
,
Robert B Wilson
3
,
Kimberly Schadt
1
2
,
David R Lynch
1
2
Affiliations
1
Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
2
Departments of Neurology and Pediatrics, University of Pennsylvania, Philadelphia, PA, United States.
3
Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
PMID:
33737864
PMCID:
PMC7960909
DOI:
10.3389/fnins.2021.653241
No abstract available
Keywords:
Ataxia; axon; biomarker; clinical trial; neurodegenerative.